345 related articles for article (PubMed ID: 17934217)
1. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.
Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST
Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.
Umeda S; Kanda M; Sugimoto H; Tanaka H; Hayashi M; Yamada S; Fujii T; Takami H; Niwa Y; Iwata N; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y
BMC Cancer; 2017 Sep; 17(1):610. PubMed ID: 28863781
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
4. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma.
Han Q; Wang X; Liao X; Han C; Yu T; Yang C; Li G; Han B; Huang K; Zhu G; Liu Z; Zhou X; Su H; Shang L; Gong Y; Song X; Peng T; Ye X
Oncol Rep; 2019 Sep; 42(3):895-910. PubMed ID: 31322232
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29a-5p is a novel predictor for early recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Zhu HT; Dong QZ; Sheng YY; Wei JW; Wang G; Zhou HJ; Ren N; Jia HL; Ye QH; Qin LX
PLoS One; 2012; 7(12):e52393. PubMed ID: 23285022
[TBL] [Abstract][Full Text] [Related]
7. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
[TBL] [Abstract][Full Text] [Related]
8. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
[TBL] [Abstract][Full Text] [Related]
9. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.
Sun W; Xing B; Sun Y; Du X; Lu M; Hao C; Lu Z; Mi W; Wu S; Wei H; Gao X; Zhu Y; Jiang Y; Qian X; He F
Mol Cell Proteomics; 2007 Oct; 6(10):1798-808. PubMed ID: 17627933
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.
Yang Z; Zhuang L; Szatmary P; Wen L; Sun H; Lu Y; Xu Q; Chen X
Int J Med Sci; 2015; 12(3):256-63. PubMed ID: 25798051
[TBL] [Abstract][Full Text] [Related]
11. Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.
Cheng SW; Tsai HW; Lin YJ; Cheng PN; Chang YC; Yen CJ; Huang HP; Chuang YP; Chang TT; Lee CT; Chao A; Chou CY; Chan SH; Chow NH; Ho CL
PLoS One; 2013; 8(11):e80053. PubMed ID: 24244607
[TBL] [Abstract][Full Text] [Related]
12. Novel proteomic biomarker panel for prediction of aggressive metastatic hepatocellular carcinoma relapse in surgically resectable patients.
Tan GS; Lim KH; Tan HT; Khoo ML; Tan SH; Toh HC; Ching Ming Chung M
J Proteome Res; 2014 Nov; 13(11):4833-46. PubMed ID: 24946162
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Mortalin in hepatocellular carcinoma and its relationship with angiogenesis and epithelial to mesenchymal transition.
Chen J; Liu WB; Jia WD; Xu GL; Ma JL; Huang M; Deng YR; Li JS
Int J Oncol; 2014 Jan; 44(1):247-55. PubMed ID: 24190572
[TBL] [Abstract][Full Text] [Related]
15. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
16. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
[TBL] [Abstract][Full Text] [Related]
18. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Wang ZS; Guo WD; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
PLoS One; 2015; 10(11):e0142727. PubMed ID: 26588210
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma.
Liu YB; Gao SL; Chen XP; Peng SY; Fang HQ; Wu YL; Peng CH; Tang Z; Xu B; Wang JW; Deng GL; Li HJ; Feng XD; Qian HR
World J Gastroenterol; 2005 Mar; 11(9):1378-81. PubMed ID: 15761980
[TBL] [Abstract][Full Text] [Related]
20. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
